Table 1.

Demographics, treatment details and outcome

Patient number	49
Men/women	30/19
Median age	30/19
Median duration of stay	14 days
Azithromycin	48/49
Hydroxychloroquine	46/49
3rd agent for community-acquired pneumonia	33/49
Escalated regime	22/49
‘PJP’ regime	8/49
Corticosteroids	11/49
PaO2/FiO2 ratio less than 200	12/49
Intubation	8
Probable cytokine release syndrome	3
Total deaths	6
Deaths directly attributed to COVID-19 infection	3